Retatrutide is a game-changer in the world of peptides, folks! It's a triple receptor agonist, meaning it targets three key hormone receptors: GLP-1, GIP, and glucagon. This unique approach makes it super effective for weight loss and managing type 2 diabetes.

 

*How it Works:*

- Suppresses appetite and increases satiety

- Regulates blood sugar levels

- Increases energy expenditure

- Promotes fat burning

- Improves insulin sensitivity

 

*Benefits:*

- Significant weight loss (up to 24.2% in 48 weeks)

- Improved glycemic control

- Reduced HbA1c levels

- Lower blood pressure

- Favorable metabolic outcomes

 

*Administration:*

- Typically administered via once-weekly injection

- Dosage varies depending on individual needs

 

*Safety:*

- Generally well-tolerated

- Common side effects include nausea and vomiting

- No significant interactions with cytochrome P450 enzymes

​

 

Overall, Retatrutide is a promising peptide that's making waves in the weight loss and metabolic health communities. Would you like to know more about its potential benefits or how it compares to other weight loss treatments?

​

• Ultra-Pure Research Grade Peptide – Minimum 98% Purity

• Supplied in sterile, flip-top headspace vials designed for laboratory use

• Manufactured to exacting standards and trusted by researchers worldwide

​​

All of our peptides are supplied strictly for research and laboratory use only. Each vial contains sterile, lyophilised powder that has been finely milled and sieved to ensure consistency. The stated weight refers to the content of a single vial. Reconstitution requires Bacteriostatic Water containing 0.9% Benzyl Alcohol (or a suitable equivalent).

 

Please note that we do not offer any advice or recommendations regarding dosage, administration, or use in humans or animals.

​

Chemical Information:

• Synonyms: Thymosin Beta-4, Timbetasin

• CAS Number: 77591-33-4

• Molecular Formula: C₂₁₂H₃₅₀N₅₆O₇₈S

• Molecular Weight: ≈4963 Da

​

​

  SOURCES ​

            1. Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and                  meta-analysis of randomized controlled trials

​

           2. Retatrutide—A Game Changer in Obesity Pharmacotherapy